Top 20 Health Care Startup Investors in Iceland (July 2026)

Portfolio highlights

• Sundra — Sundra is a translation software that helps HR teams translate their learning content so every employee feels included.
• HorseDay — HorseDay is a mobile application to track horse activities.
• Arcana Bio — ArcanaBio is developing realtime biosurveillance solutions that minimize workplace disruptions and support health & wellness

Portfolio highlights

• Optise — Optise is an AI-powered website insights tool for B2B businesses.
• MyDello — Get instant quotes for all transportation modes. Enter a new era of freight forwarding with the MyDello logistics platform. Sign up for free
• Euler —

Portfolio highlights

• Numan — Convenient care, tailored to you. Offering treatments for weight loss, diagnostics, erectile dysfunction, hair loss, and more.
• Nord Security — Nord Security is the leader in the field of online privacy and security. Our security tools have earned praise from respected experts and tech outlets.
• Steel City Interactive — Steel City Interactive develops gaming.

Portfolio highlights

• Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
• AviLabs — AviLabs specializes in software development in aviation.
• Ghostlamp — Ghostlamp enables brands and agencies to create on-demand micro influencer campaigns, anywhere in the world via the use of an online self-serve platform.

Portfolio highlights

• PLAIO — PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
• EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases

Portfolio highlights

• Soptle — Founded in Sep 2021, Soptle started to establish an integrated technology to the neglected regional FMCG Manufacturers in India with a B2B Retail Commmerce App. It uses tech and data to distribute at scale and use necessary components (existing Distributor/Wholesaler) in the FMCG Supply Chain to build a high growth and profitable business.
• Sundra — Sundra is a translation software that helps HR teams translate their learning content so every employee feels included.
• Expertrons — Expertrons is an upskilling platform that offers advanced training programs | BSFI | HR | Marketing and many more to assure 100% professional success.

Portfolio highlights

• Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
• Oculis — Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.

Portfolio highlights

• Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
• Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
• Augmented Hearing — Augmented Hearing is creating game-changing technology that will be used in fields such as voice assistants, hearing health, environmental noise suppression in phone calls, and many more.

Portfolio highlights

• nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
• Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
• Beren Therapeutics — Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient. The company was founded in 2020 and is based in Thousand Oaks, CA.

Portfolio highlights

• 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.

Portfolio highlights

• Genis — Genis is pioneering the development and application of therapeutic chitin derivatives.

Portfolio highlights

• Genis — Genis is pioneering the development and application of therapeutic chitin derivatives.

Portfolio highlights

• Genis — Genis is pioneering the development and application of therapeutic chitin derivatives.

Portfolio highlights

• Genis — Genis is pioneering the development and application of therapeutic chitin derivatives.
• Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.

Portfolio highlights

• Polka Pop — Polka Pop is India's first brand to serve naturally flavored sparkling water with zero calories and no added sugar. Supporting a sustainable lifestyle choice, this healthy drink is available in four flavors, i.e. lemon-lime, orange, peach, and cranberry. The fizz makes this the best mix for cocktails and mocktails.
• EpiEndo Pharmaceuticals — Welcome to EpiEndo Pharma | Developing epithelial barrier enhancing drugs to treat chronic respiratory diseases

Portfolio highlights

• PLAIO — PLAIO is a web-based SaaS platform intended to help generic pharmaceutical companies to digitize their demand, manufacturing, and purchase planning.PLAIO offers features like visual and capacity planning, advanced constraint/overhead calculations.
• Kara Connect — Kara Connect is the easiest and most powerful way to get employees access to the support they need, when they need it.

Portfolio highlights

• Axelyf — Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
• Meniga — Meniga helps banks use data to drive Digital Engagement, build Customer Loyalty & increase Revenue.
• Treble — We develop next generation sound simulation and spatial audio technology for digital twins and virtual worlds.

Portfolio highlights

• Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Portfolio highlights

• Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
• KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
• XNK Therapeutics — XNK Therapeutics, founded in 2012, is one of the pioneering companies within the landscape of cell therapy.

Portfolio highlights

• 3Z Pharmaceuticals — 3Z Pharmaceuticals provides research services intended to provide drug development services. It offers drug screening on sleep and epilepsy assays that helps in the development of drugs used to treat neurological disorders, enabling patients to get multiple drug efficacy and toxicity assays.Karl Karlsson and Haraldur Thorsteinsson founded 3ZPharmaceuticals in 2008. It based their company on their research on the sleeping patterns of the zebrafish at the Reykjavik University Neurolab in 2006.